Company Data

G1 Therapeutics Inc.

Ticker
GTHX
Current Price
$7.15
Market Cap
$377.2M
Price Target
Refer to Report
Volume
148.0K
52wk Range
$1.08 - $7.19
Advanced Market Data

Overview

G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat most types of cancer, such as cell lung cancer and breast cancer, and designs them to combine – and enhance – the anti-tumor activity of current therapies.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy